CN111388522A - Plant essence for preventing, treating and repairing scar hyperplasia and preparation method thereof - Google Patents

Plant essence for preventing, treating and repairing scar hyperplasia and preparation method thereof Download PDF

Info

Publication number
CN111388522A
CN111388522A CN202010235022.1A CN202010235022A CN111388522A CN 111388522 A CN111388522 A CN 111388522A CN 202010235022 A CN202010235022 A CN 202010235022A CN 111388522 A CN111388522 A CN 111388522A
Authority
CN
China
Prior art keywords
powder
raw material
weight
deionized water
hours
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202010235022.1A
Other languages
Chinese (zh)
Other versions
CN111388522B (en
Inventor
孟令超
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chenfeng Natural Herbal Beijing Technology Co ltd
Original Assignee
Chenfeng Natural Herbal Beijing Technology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chenfeng Natural Herbal Beijing Technology Co ltd filed Critical Chenfeng Natural Herbal Beijing Technology Co ltd
Priority to CN202010235022.1A priority Critical patent/CN111388522B/en
Publication of CN111388522A publication Critical patent/CN111388522A/en
Application granted granted Critical
Publication of CN111388522B publication Critical patent/CN111388522B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484—Glycyrrhiza (licorice)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/489—Sophora, e.g. necklacepod or mamani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50—Methods involving additional extraction steps
    • A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)

Abstract

The invention discloses a plant essence for preventing and repairing scar hyperplasia and a preparation method thereof, wherein the plant essence comprises the following raw materials in percentage by weight: 0.5-10% of pseudo-ginseng extract powder, 0.5-10% of licorice extract powder, 0.5-10% of sophora flower bud extract powder and the balance of solvent, wherein the total weight percentage of the raw materials is 100%. The invention can effectively activate immune cell population of a wound part, inhibit macrophage polarization, inhibit expression of inflammatory factors and trend factors, inhibit proliferation and differentiation of fibroblasts, reduce ECM (extracellular matrix) deposition, promote regeneration of capillary vessels around pathological changes, improve microcirculation, prevent and repair scar hyperplasia from inside to outside, and has very high safety.

Description

Plant essence for preventing, treating and repairing scar hyperplasia and preparation method thereof
Technical Field
The invention relates to the field of biological medicines, in particular to a plant essence for preventing and repairing scar hyperplasia and a preparation method thereof.
Background
Scars are one of the most common complications after wound healing and are always a difficult point and a hot point for research in the field of surgical repair. Not only does excessive scar proliferation affect the cosmetic appearance of the patient, but the resulting spasms can lead to varying degrees of dysfunction, placing a heavy economic and psychological burden on the later treatment of such patients.
Scar formation is actually only a stage in skin trauma, and therefore understanding the process of skin healing is a critical loop for scar repair. From a pathological point of view, healing of skin wounds generally falls into four stages: hemostasis, inflammatory responses, cell proliferation/matrix precipitation and skin tissue remodeling, these phases being mediated by a cascade of immune cells and signaling molecules. In the process of skin wound healing, fibroblasts, keratinocytes and epithelial cells are accumulated at the site of injury, and scar formation begins in the third phase of wound healing. In this stage, fibroblasts differentiate into myofibroblasts, which secrete and synthesize new ECM (extracellular matrix). The new ECM is remodeled to form scar tissue. Meanwhile, cytokines secreted by leukocytes play a direct role not only in the initial aggregation of fibroblasts, but also play a key role in mediating the development of scar formation in general inflammatory responses. At present, the commonly used treatment techniques in the aspect of scar treatment include surgical operations such as skin grafting, laser treatment, skin dilator treatment, excision and suture, grinding, treatment by using simple hormone drugs such as dexamethasone, freezing treatment and the like. The technologies relieve the symptoms of patients to different degrees, but the non-drug treatment in the methods has the defects of higher cost, more pain of patients, long operation treatment time and the like, and the diseases are easy to relapse after recovery. The treatment with the steroid hormone medicines such as dexamethasone may cause harm to the body and even cause sterility, osteoporosis and the like.
The existing products for preventing and repairing various scars have certain limitations. The invention provides a plant essence for preventing and repairing scar hyperplasia and a preparation method thereof. The product combines the traditional Chinese herbal medicine and western pharmacology, selects the traditional Chinese medicines of pseudo-ginseng, liquorice and sophora flower which have the functions of removing blood stasis, promoting tissue regeneration, resisting inflammation, sterilizing, activating immunity, whitening and lightening spots, and enriches dammarane type tetracyclic pentaplenin (ginsenoside Rb) by an extraction and purification technology1、Rg1Rd, notoginsenoside R1Etc.), glycyrrhizin and flavone, rutin and plant polysaccharide, etc., can effectively activate immune cell population of wound parts, inhibit macrophage polarization, inhibit expression of inflammatory factors and trend factors, inhibit proliferation and differentiation of fibroblasts, reduce ECM (extracellular matrix) deposition, promote regeneration of capillary vessels around pathological changes, improve microcirculation, prevent and repair scar hyperplasia from inside to outside, and has high safety.
Disclosure of Invention
The invention aims to provide a plant essence for preventing and repairing scar hyperplasia and a preparation method thereof, and aims to solve the problems in the background technology.
In order to achieve the purpose, the invention provides the following technical scheme:
the plant essence for preventing and repairing scar hyperplasia comprises the following raw materials in percentage by weight: 0.5-10% of pseudo-ginseng extract powder, 0.5-10% of licorice extract powder, 0.5-10% of sophora flower bud extract powder and the balance of solvent, wherein the sum of the weight percentages of the raw materials and the solvent is 100%.
In some embodiments, the botanical essence comprises the following raw materials in weight percent: 2-10% of pseudo-ginseng extract powder, 2-10% of licorice extract powder, 2-10% of sophora flower bud extract powder and the balance of solvent, wherein the sum of the weight percentages of the raw materials and the solvent is 100%.
In some embodiments, the solvent is a mixture of 60% to 90% by weight of glycerol and deionized water.
In some embodiments, the solvent is a mixture of 60% to 90% by weight of 1, 3 propanediol and deionized water.
In some embodiments, the solvent is a mixture of 60 to 90 weight percent 1, 3 butanediol and deionized water.
In some embodiments, the panax notoginseng extract powder is prepared by the following method:
1) grinding Notoginseng radix into powder with a pulverizer, and sieving with a 20 mesh sieve to obtain raw material powder for use;
2) adding raw material powder into deionized water with the weight 5-8 times of that of the raw material powder, stirring and extracting for 4-6 hours at the temperature of 60-90 ℃, and filtering to obtain primary filtrate and primary extraction slag;
3) adding deionized water with the weight being 3-6 times that of the primary extracted material slag, stirring and extracting for 2-4 hours at the temperature of 60-90 ℃, and filtering to obtain secondary filtrate and secondary extracted material slag;
4) and (3) combining the primary filtrate and the secondary filtrate, concentrating until the solid content is 10-20%, and performing spray drying to obtain the pseudo-ginseng extract powder.
In some embodiments, the ginseng extract powder is prepared by:
1) grinding ginseng roots into powder by using a grinder, and sieving the powder by using a 20-mesh sieve to obtain raw material powder for later use;
2) adding raw material powder into deionized water with the weight 5-8 times of that of the raw material powder, stirring and extracting for 4-6 hours at the temperature of 60-90 ℃, and filtering to obtain primary filtrate and primary extraction slag;
3) adding deionized water with the weight being 3-6 times that of the primary extracted material slag, stirring and extracting for 2-4 hours at the temperature of 60-90 ℃, and filtering to obtain secondary filtrate and secondary extracted material slag;
4) and (3) combining the primary filtrate and the secondary filtrate, concentrating until the solid content is 10-20%, and performing spray drying to obtain the ginseng extract powder.
In some embodiments, the licorice extract powder is prepared by the following method:
1) grinding Glycyrrhrizae radix into powder with a grinder, and sieving with 20 mesh sieve to obtain raw material powder;
2) adding raw material powder into deionized water with the weight 5-8 times of that of the raw material powder, stirring and extracting for 4-6 hours at the temperature of 60-90 ℃, and filtering to obtain primary filtrate and primary extraction slag;
3) adding deionized water with the weight being 3-6 times that of the primary extracted material slag, stirring and extracting for 2-4 hours at the temperature of 60-90 ℃, and filtering to obtain secondary filtrate and secondary extracted material slag;
4) and (3) combining the primary filtrate and the secondary filtrate, concentrating until the solid content is 10-20%, and performing spray drying to obtain licorice extract powder.
In some embodiments, the sophora flower bud extract powder is prepared by the following method:
1) pulverizing flos Sophorae Immaturus into powder with a pulverizer, and sieving with a 20-mesh sieve to obtain raw material powder;
2) adding raw material powder into deionized water with the weight 5-8 times of that of the raw material powder, stirring and extracting for 4-6 hours at the temperature of 60-90 ℃, and filtering to obtain primary filtrate and primary extraction slag;
3) adding deionized water with the weight being 3-6 times that of the primary extracted material slag, stirring and extracting for 2-4 hours at the temperature of 60-90 ℃, and filtering to obtain secondary filtrate and secondary extracted material slag;
4) and (3) combining the primary filtrate and the secondary filtrate, concentrating until the solid content is 10-20%, and performing spray drying to obtain sophora flower bud extract powder.
The invention also provides a preparation method of the plant essence, which is characterized by comprising the following steps:
1) grinding Notoginseng radix into powder with a pulverizer, and sieving with a 20 mesh sieve to obtain raw material powder for use; then adding the raw material powder into deionized water with the weight 5-8 times of that of the raw material powder, stirring and extracting for 4-6 hours at the temperature of 60-90 ℃, and filtering to obtain primary filtrate; adding deionized water with the weight being 3-6 times that of the primary extraction slag, stirring and extracting for 2-4 hours at the temperature of 60-90 ℃, and filtering to obtain secondary filtrate; mixing the two filtrates, concentrating until the solid content is 10-20%, and performing spray drying to obtain radix Notoginseng extract powder for later use;
2) grinding ginseng roots into powder by using a grinder, and sieving the powder by using a 20-mesh sieve to obtain raw material powder for later use; then adding the raw material powder into deionized water with the weight 5-8 times of that of the raw material powder, stirring and extracting for 4-6 hours at the temperature of 60-90 ℃, and filtering to obtain primary filtrate; adding deionized water with the weight being 3-6 times that of the primary extraction slag, stirring and extracting for 2-4 hours at the temperature of 60-90 ℃, and filtering to obtain secondary filtrate; mixing and concentrating the two filtrates until the solid content is 10-20%, and performing spray drying to obtain ginseng extract powder for later use;
3) grinding Glycyrrhrizae radix into powder with a grinder, and sieving with 20 mesh sieve to obtain raw material powder; then adding the raw material powder into deionized water with the weight 5-8 times of that of the raw material powder, stirring and extracting for 4-6 hours at the temperature of 60-90 ℃, and filtering to obtain primary filtrate; adding deionized water with the weight being 3-6 times that of the primary extraction slag, stirring and extracting for 2-4 hours at the temperature of 60-90 ℃, and filtering to obtain secondary filtrate; mixing and concentrating the two filtrates until the solid content is 10-20%, and performing spray drying to obtain licorice extract powder for later use;
4) pulverizing flos Sophorae Immaturus into powder with a pulverizer, and sieving with a 20-mesh sieve to obtain raw material powder; then adding the raw material powder into deionized water with the weight 5-8 times of that of the raw material powder, stirring and extracting for 4-6 hours at the temperature of 60-90 ℃, and filtering to obtain primary filtrate; adding deionized water with the weight being 3-6 times that of the primary extraction slag, stirring and extracting for 2-4 hours at the temperature of 60-90 ℃, and filtering to obtain secondary filtrate; and combining and concentrating the two filtrates until the solid content is 10-20%, and performing spray drying to obtain sophora flower bud extract powder for later use.
In some embodiments, the plant essence of the present invention is prepared by the following method: mixing 0.5-10% of pseudo-ginseng extract powder, 0.5-10% of licorice extract powder and 0.5-10% of sophora flower bud extract powder. And then adding the rest solvent into the mixed extract powder, heating to 45-80 ℃, refluxing, stirring until the mixture is completely dissolved, adding 5-20% of activated carbon for decolorization, filtering, cooling the filtrate to room temperature, standing for 1-3 days, and filtering again to obtain a finished product.
Compared with the prior art, the invention has the characteristics and advantages that:
the invention is a plant formula product, and the combined formula is not reported in other related scientific researches, and has uniqueness and originality. The product combines the traditional Chinese herbal medicine and western pharmacology, selects the traditional Chinese medicines of notoginseng, ginseng, liquorice and sophora flower bud with the functions of removing blood stasis, promoting tissue regeneration, resisting inflammation, sterilizing, activating immunity, whitening and lightening spots, and enriches the effective active ingredient dammarane type tetracyclic pentapenoid saponins (ginsenoside Rb) by an extraction and purification technology1、Rg1Rd, notoginsenoside R1Etc.), glycyrrhizin and flavone, rutin and plant polysaccharide, etc., can effectively activate immune cell population of wound parts, inhibit macrophage polarization, inhibit expression of inflammatory factors and trend factors, inhibit proliferation and differentiation of fibroblasts, reduce ECM (extracellular matrix) deposition, simultaneously promote regeneration of capillary vessels around pathological changes, improve microcirculation, prevent and cure and repair scar hyperplasia from inside to outside, and have very high safety.
Drawings
FIG. 1: the action mechanism diagram of the plant essence for preventing, treating and repairing scar hyperplasia is provided.
FIG. 2 is a bar graph showing the inhibitory effect of example 2 on L PS-induced RAW264.7 cells producing the inflammatory factors TNF- α, I L-6 and I L-8.
FIG. 3: histogram reflecting the inhibitory effect of example 2 on scar area generation in rabbit ear model.
FIG. 4: histogram reflecting the inhibitory effect of example 2 on collagen I concentration in scar tissue in rabbit ear model.
FIG. 5: histogram reflecting the inhibitory effect of example 2 on collagen III concentration in scar tissue in rabbit ear model.
Detailed Description
The technical solution of the present patent will be described in further detail with reference to the following embodiments.
Example 1
The plant essence for preventing and repairing scar hyperplasia comprises the following raw materials in percentage by weight: 2% of pseudo-ginseng extract powder, 2% of licorice extract powder, 2% of sophora flower bud extract powder, 15% of glycerol and 77% of deionized water, wherein the total weight percentage of the raw materials is 100%.
A preparation method of plant essence for preventing and repairing scar hyperplasia comprises the following steps:
(1) grinding Notoginseng radix into powder with a pulverizer, and sieving with 20 mesh sieve to obtain raw material powder for use. Then, the raw material powder was added to 6 times of deionized water, stirred and extracted at 90 ℃ for 4 hours, and filtered to obtain a primary filtrate. And adding deionized water with the weight being 4 times that of the primary extraction slag, stirring and extracting for 2 hours at the temperature of 90 ℃, and filtering to obtain secondary filtrate. Mixing the two filtrates, concentrating until solid content is 15%, and spray drying to obtain Notoginseng radix extract powder.
(2) Pulverizing Ginseng radix into powder with a pulverizer, and sieving with 20 mesh sieve to obtain raw material powder. Then, the raw material powder was added to 6 times of deionized water, stirred and extracted at 90 ℃ for 4 hours, and filtered to obtain a primary filtrate. And adding deionized water with the weight being 4 times that of the primary extraction slag, stirring and extracting for 2 hours at the temperature of 90 ℃, and filtering to obtain secondary filtrate. Mixing the two filtrates, concentrating until solid content is 15%, and spray drying to obtain Ginseng radix extract powder.
(3) Pulverizing Glycyrrhrizae radix into powder with a pulverizer, and sieving with 20 mesh sieve to obtain raw material powder. Then, the raw material powder was added to 6 times of deionized water, stirred and extracted at 90 ℃ for 4 hours, and filtered to obtain a primary filtrate. And adding deionized water with the weight being 4 times that of the primary extraction slag, stirring and extracting for 2 hours at the temperature of 90 ℃, and filtering to obtain secondary filtrate. Mixing the two filtrates, concentrating until solid content is 15%, and spray drying to obtain Glycyrrhrizae radix extract powder.
(4) Pulverizing flos Sophorae Immaturus into powder with a pulverizer, and sieving with 20 mesh sieve to obtain raw material powder. Then, the raw material powder was added to 6 times of deionized water, stirred and extracted at 90 ℃ for 4 hours, and filtered to obtain a primary filtrate. And adding deionized water with the weight being 4 times that of the primary extraction slag, stirring and extracting for 2 hours at the temperature of 90 ℃, and filtering to obtain secondary filtrate. Mixing the two filtrates, concentrating until the solid content is 15%, and spray drying to obtain flos Sophorae Immaturus extract powder for use.
(5) Mixing 2% of the panax notoginseng extract powder, 2% of the ginseng extract powder, 2% of the liquorice extract powder and 2% of the sophora flower bud extract powder according to the total mass percentage of the raw materials.
(6) And then adding 15% of glycerol and 77% of deionized water into the mixed extract powder, heating to 60 ℃, refluxing, stirring until the mixture is completely dissolved, adding 10% of activated carbon for decolorization, filtering, cooling the filtrate to room temperature, standing for 2 days, and filtering again to obtain a finished product.
Example 2
The plant essence for preventing and repairing scar hyperplasia comprises the following raw materials in percentage by weight: 5% of pseudo-ginseng extract powder, 5% of licorice extract powder, 5% of sophora flower bud extract powder, 10% of 1, 2-propylene glycol and 70% of deionized water, wherein the sum of the weight percentages of the raw materials is 100%.
A preparation method of plant essence for preventing and repairing scar hyperplasia comprises the following steps:
(1) grinding Notoginseng radix into powder with a pulverizer, and sieving with 20 mesh sieve to obtain raw material powder for use. Then, the raw material powder was added to 6 times of deionized water, stirred and extracted at 90 ℃ for 4 hours, and filtered to obtain a primary filtrate. And adding deionized water with the weight being 4 times that of the primary extraction slag, stirring and extracting for 2 hours at the temperature of 90 ℃, and filtering to obtain secondary filtrate. Mixing the two filtrates, concentrating until solid content is 15%, and spray drying to obtain Notoginseng radix extract powder.
(2) Pulverizing Ginseng radix into powder with a pulverizer, and sieving with 20 mesh sieve to obtain raw material powder. Then, the raw material powder was added to 6 times of deionized water, stirred and extracted at 90 ℃ for 4 hours, and filtered to obtain a primary filtrate. And adding deionized water with the weight being 4 times that of the primary extraction slag, stirring and extracting for 2 hours at the temperature of 90 ℃, and filtering to obtain secondary filtrate. Mixing the two filtrates, concentrating until solid content is 15%, and spray drying to obtain Ginseng radix extract powder.
(3) Pulverizing Glycyrrhrizae radix into powder with a pulverizer, and sieving with 20 mesh sieve to obtain raw material powder. Then, the raw material powder was added to 6 times of deionized water, stirred and extracted at 90 ℃ for 4 hours, and filtered to obtain a primary filtrate. And adding deionized water with the weight being 4 times that of the primary extraction slag, stirring and extracting for 2 hours at the temperature of 90 ℃, and filtering to obtain secondary filtrate. Mixing the two filtrates, concentrating until solid content is 15%, and spray drying to obtain Glycyrrhrizae radix extract powder.
(4) Pulverizing flos Sophorae Immaturus into powder with a pulverizer, and sieving with 20 mesh sieve to obtain raw material powder. Then, the raw material powder was added to 6 times of deionized water, stirred and extracted at 90 ℃ for 4 hours, and filtered to obtain a primary filtrate. And adding deionized water with the weight being 4 times that of the primary extraction slag, stirring and extracting for 2 hours at the temperature of 90 ℃, and filtering to obtain secondary filtrate. Mixing the two filtrates, concentrating until the solid content is 15%, and spray drying to obtain flos Sophorae Immaturus extract powder for use.
(5) Mixing 5% of the panax notoginseng extract powder, 5% of the ginseng extract powder, 5% of the liquorice extract powder and 5% of the sophora flower bud extract powder according to the total mass percentage of the raw materials.
(6) Then adding 10% of 1, 2-propylene glycol and 70% of deionized water into the mixed extract powder, heating to 50 ℃ for refluxing, stirring until the mixture is completely dissolved, adding 15% of activated carbon for decoloring, filtering, cooling the filtrate to room temperature, standing for 3 days, and filtering again to obtain the finished product.
Example 3
The plant essence for preventing and repairing scar hyperplasia comprises the following raw materials in percentage by weight: 10% of pseudo-ginseng extract powder, 10% of liquorice extract powder, 10% of sophora flower bud extract powder, 18% of 1, 3-butanediol and 42% of deionized water, wherein the sum of the weight percentages of the raw materials is 100%.
A preparation method of plant essence for preventing and repairing scar hyperplasia comprises the following steps:
(1) grinding Notoginseng radix into powder with a pulverizer, and sieving with 20 mesh sieve to obtain raw material powder for use. Then, the raw material powder was added to 6 times of deionized water, stirred and extracted at 90 ℃ for 4 hours, and filtered to obtain a primary filtrate. And adding deionized water with the weight being 4 times that of the primary extraction slag, stirring and extracting for 2 hours at the temperature of 90 ℃, and filtering to obtain secondary filtrate. Mixing the two filtrates, concentrating until solid content is 15%, and spray drying to obtain Notoginseng radix extract powder.
(2) Pulverizing Ginseng radix into powder with a pulverizer, and sieving with 20 mesh sieve to obtain raw material powder. Then, the raw material powder was added to 6 times of deionized water, stirred and extracted at 90 ℃ for 4 hours, and filtered to obtain a primary filtrate. And adding deionized water with the weight being 4 times that of the primary extraction slag, stirring and extracting for 2 hours at the temperature of 90 ℃, and filtering to obtain secondary filtrate. Mixing the two filtrates, concentrating until solid content is 15%, and spray drying to obtain Ginseng radix extract powder.
(3) Pulverizing Glycyrrhrizae radix into powder with a pulverizer, and sieving with 20 mesh sieve to obtain raw material powder. Then, the raw material powder was added to 6 times of deionized water, stirred and extracted at 90 ℃ for 4 hours, and filtered to obtain a primary filtrate. And adding deionized water with the weight being 4 times that of the primary extraction slag, stirring and extracting for 2 hours at the temperature of 90 ℃, and filtering to obtain secondary filtrate. Mixing the two filtrates, concentrating until solid content is 15%, and spray drying to obtain Glycyrrhrizae radix extract powder.
(4) Pulverizing flos Sophorae Immaturus into powder with a pulverizer, and sieving with 20 mesh sieve to obtain raw material powder. Then, the raw material powder was added to 6 times of deionized water, stirred and extracted at 90 ℃ for 4 hours, and filtered to obtain a primary filtrate. And adding deionized water with the weight being 4 times that of the primary extraction slag, stirring and extracting for 2 hours at the temperature of 90 ℃, and filtering to obtain secondary filtrate. Mixing the two filtrates, concentrating until the solid content is 15%, and spray drying to obtain flos Sophorae Immaturus extract powder for use.
(5) Mixing 10% of the panax notoginseng extract powder, 10% of the ginseng extract powder, 10% of the liquorice extract powder and 10% of the sophora flower bud extract powder according to the total mass percentage of the raw materials.
(6) Then adding 15% of 1, 3-butanediol and 45% of deionized water into the mixed extract powder, heating to 60 ℃, refluxing, stirring until the mixture is completely dissolved, adding 20% of activated carbon for decolorization, filtering, cooling the filtrate to room temperature, standing for 3 days, and filtering again to obtain the finished product.
The product of the invention is rich in dammarane type tetracyclic pentadecanoid saponins (ginsenoside Rb)1、Rg1Rd, notoginsenoside R1Etc.), glycyrrhizin and flavone, rutin and plant polysaccharide, etc., can effectively activate immune cell population of wound parts, inhibit macrophage polarization, inhibit expression of inflammatory factors and trend factors, inhibit proliferation and differentiation of fibroblasts, reduce ECM (extracellular matrix) deposition, promote regeneration of capillary vessels around pathological changes, improve microcirculation, prevent and cure scar hyperplasia from inside to outside, etc. The possible mechanism of action is shown in figure 1. In order to verify the effect of the plant essence of the invention in preventing and repairing scar hyperplasia, the following tests are carried out:
anti-inflammatory Activity assay
A large number of scientific reports prove that the generation of acute and chronic inflammation, wound healing and scar formation are directly and indirectly related, inflammatory factors can mediate the proliferation and differentiation of fibroblasts and promote the secretion and deposition of ECM, and are key targets for scar hyperplasia, so that the inhibition and reduction of inflammatory response are important links for preventing and repairing scar hyperplasia, wherein TNF- α, I L-6 and I L-8 are key inflammatory expression factors.
L PS (L ipopolysaccharide, lipopolysaccharide used at a concentration of 1. mu.g/ml) was used in the experiment to induce an inflammatory response in RAW264.7 (mouse mononuclear macrophages), the product of example 2 of the invention (used at a concentration of 500ug/ml) was used for treatment, and finally the expression of the inflammatory factors TNF- α, I L-6 and I L-8 was evaluated using E L ISA (Enzyme linked immunosorbent assay). The results of the experiment are shown in FIG. 2.
As can be seen from the test results, when L PS is used for inducing RAW264.7, the expressions of TNF- α, I L-6 and I L-8 are remarkably increased compared with a blank Control group (Control), which indicates that L PS induces inflammation, and when the product is treated by the invention of example 2 with the concentration of 500 mug/ml, the expressions of TNF- α, I L-6 and I L-8 are greatly reduced, which indicates that the product of the invention has remarkable inhibition effect on the expression of inflammatory factors induced by L PS.
Second, animal body test for inhibiting scar hyperplasia (rabbit ear model)
1. Influence on scar area
The test uses 10 healthy New Zealand rabbits (2.0-2.2 kg body weight) which are divided equally into two groups: a circular puncture wound (D ═ 1CM) was made in the ear belly of both rabbits in the blank group (5) and treatment group (5) to create a scar model. Starting on day 14 of the wound, the treatment group treated the wound daily with a 2% by weight sterile aqueous solution containing example 2 for 10 days, and the blank group was treated with an equal amount of 1% physiological saline for 10 days. Scar area differences were measured at day 30. The results are shown in FIG. 3 as the mean standard deviation.
From the test results, the average scar area of the treatment group treated by the example 2 is reduced by 38% compared with that of the blank group, which shows that the product of the invention has the function of inhibiting the generation of scars and can obviously reduce the hyperplasia of scars.
2. Influence on collagen synthesis
In the wound healing process, the production of collagen can be said to be a twolip sword, which is essential for the healing process on the one hand; on the other hand, overproduction and excessive deposition of collagen can lead to excessive scar proliferation. While the production of collagen and ECM is mainly mediated by the hyperproliferation and secretion of myofibroblasts. Numerous reports on scar-related scientific research have also demonstrated that: by inhibiting proliferation and differentiation of fibroblasts, excessive production of collagen and ECM can be inhibited, thereby effectively inhibiting proliferation of scar tissue. In the test, scar tissues in a healthy group, a control group and a treatment group treated in the embodiment 2 of the rabbit ear model are sampled, and the content of collagen I and collagen III is measured to evaluate the influence of the product on the collagen, so that the inhibition effect of the product on scar hyperplasia is further verified.
In the two groups of rabbit ear models, hypertrophic scar tissue of one rabbit ear in each group is sampled respectively at the 7 th day and the 30 th day after treatment, and simultaneously, tissue of any healthy part is sampled, namely, the rabbit ear is divided into a healthy group, a blank group and a treatment group at each time point, after the sample passes through the treatment, the content of collagen I and collagen III is measured on the treated sample by using E L ISA (Enzyme linked immunosorbent assay), and the test results are shown in fig. 4 and fig. 5.
From the test results, the contents of collagen I and collagen III in the scar tissue of the treatment group treated by the product of the invention are greatly reduced compared with the blank group, and the concentration of the scar tissue is closer to that of the healthy group. This shows that the test product can effectively inhibit the generation of collagen, thereby inhibiting the excessive proliferation of scars.
Although the present invention has been described with reference to the preferred embodiments, it should be understood that various changes, substitutions and alterations can be made herein without departing from the spirit and scope of the invention as defined by the appended claims.

Claims (10)

1. The plant essence for preventing and repairing scar hyperplasia is characterized by comprising the following raw materials in percentage by weight: 0.5-10% of pseudo-ginseng extract powder, 0.5-10% of licorice extract powder, 0.5-10% of sophora flower bud extract powder and the balance of solvent, wherein the sum of the weight percentages of the raw materials and the solvent is 100%.
2. The plant essence according to claim 1, wherein the plant essence comprises the following raw materials in percentage by weight: 2-10% of pseudo-ginseng extract powder, 2-10% of licorice extract powder, 2-10% of sophora flower bud extract powder and the balance of solvent, wherein the sum of the weight percentages of the raw materials and the solvent is 100%.
3. The plant essence according to claim 1, wherein the solvent is a mixture of 60-90 wt% of glycerin and deionized water.
4. The plant essence according to claim 1, wherein the solvent is a mixture of 60-90 wt% of 1, 3-propanediol and deionized water.
5. The plant essence according to claim 1, wherein the solvent is a mixture of 60 to 90 weight percent of 1, 3-butanediol and deionized water.
6. The plant essence according to claim 1, wherein the notoginseng extract powder is prepared by the following method:
1) grinding Notoginseng radix into powder with a pulverizer, and sieving with a 20 mesh sieve to obtain raw material powder for use;
2) adding raw material powder into deionized water with the weight 5-8 times of that of the raw material powder, stirring and extracting for 4-6 hours at the temperature of 60-90 ℃, and filtering to obtain primary filtrate and primary extraction slag;
3) adding deionized water with the weight being 3-6 times that of the primary extracted material slag, stirring and extracting for 2-4 hours at the temperature of 60-90 ℃, and filtering to obtain secondary filtrate and secondary extracted material slag;
4) and (3) combining the primary filtrate and the secondary filtrate, concentrating until the solid content is 10-20%, and performing spray drying to obtain the pseudo-ginseng extract powder.
7. The plant essence of claim 1, wherein the ginseng extract powder is prepared by the following method:
1) grinding ginseng roots into powder by using a grinder, and sieving the powder by using a 20-mesh sieve to obtain raw material powder for later use;
2) adding raw material powder into deionized water with the weight 5-8 times of that of the raw material powder, stirring and extracting for 4-6 hours at the temperature of 60-90 ℃, and filtering to obtain primary filtrate and primary extraction slag;
3) adding deionized water with the weight being 3-6 times that of the primary extracted material slag, stirring and extracting for 2-4 hours at the temperature of 60-90 ℃, and filtering to obtain secondary filtrate and secondary extracted material slag;
4) and (3) combining the primary filtrate and the secondary filtrate, concentrating until the solid content is 10-20%, and performing spray drying to obtain the ginseng extract powder.
8. The plant essence of claim 1, wherein the licorice extract powder is prepared by the following method:
1) grinding Glycyrrhrizae radix into powder with a grinder, and sieving with 20 mesh sieve to obtain raw material powder;
2) adding raw material powder into deionized water with the weight 5-8 times of that of the raw material powder, stirring and extracting for 4-6 hours at the temperature of 60-90 ℃, and filtering to obtain primary filtrate and primary extraction slag;
3) adding deionized water with the weight being 3-6 times that of the primary extracted material slag, stirring and extracting for 2-4 hours at the temperature of 60-90 ℃, and filtering to obtain secondary filtrate and secondary extracted material slag;
4) and (3) combining the primary filtrate and the secondary filtrate, concentrating until the solid content is 10-20%, and performing spray drying to obtain licorice extract powder.
9. The plant essence of claim 1, wherein the sophora flower bud extract powder is prepared by the following method:
1) pulverizing flos Sophorae Immaturus into powder with a pulverizer, and sieving with a 20-mesh sieve to obtain raw material powder;
2) adding raw material powder into deionized water with the weight 5-8 times of that of the raw material powder, stirring and extracting for 4-6 hours at the temperature of 60-90 ℃, and filtering to obtain primary filtrate and primary extraction slag;
3) adding deionized water with the weight being 3-6 times that of the primary extracted material slag, stirring and extracting for 2-4 hours at the temperature of 60-90 ℃, and filtering to obtain secondary filtrate and secondary extracted material slag;
4) and (3) combining the primary filtrate and the secondary filtrate, concentrating until the solid content is 10-20%, and performing spray drying to obtain sophora flower bud extract powder.
10. A method for preparing the plant essence according to any one of claims 1 to 4, comprising the steps of:
1) grinding Notoginseng radix into powder with a pulverizer, and sieving with a 20 mesh sieve to obtain raw material powder for use; then adding the raw material powder into deionized water with the weight 5-8 times of that of the raw material powder, stirring and extracting for 4-6 hours at the temperature of 60-90 ℃, and filtering to obtain primary filtrate; adding deionized water with the weight being 3-6 times that of the primary extraction slag, stirring and extracting for 2-4 hours at the temperature of 60-90 ℃, and filtering to obtain secondary filtrate; mixing the two filtrates, concentrating until the solid content is 10-20%, and performing spray drying to obtain radix Notoginseng extract powder for later use;
2) grinding ginseng roots into powder by using a grinder, and sieving the powder by using a 20-mesh sieve to obtain raw material powder for later use; then adding the raw material powder into deionized water with the weight 5-8 times of that of the raw material powder, stirring and extracting for 4-6 hours at the temperature of 60-90 ℃, and filtering to obtain primary filtrate; adding deionized water with the weight being 3-6 times that of the primary extraction slag, stirring and extracting for 2-4 hours at the temperature of 60-90 ℃, and filtering to obtain secondary filtrate; mixing and concentrating the two filtrates until the solid content is 10-20%, and performing spray drying to obtain ginseng extract powder for later use;
3) grinding Glycyrrhrizae radix into powder with a grinder, and sieving with 20 mesh sieve to obtain raw material powder; then adding the raw material powder into deionized water with the weight 5-8 times of that of the raw material powder, stirring and extracting for 4-6 hours at the temperature of 60-90 ℃, and filtering to obtain primary filtrate; adding deionized water with the weight being 3-6 times that of the primary extraction slag, stirring and extracting for 2-4 hours at the temperature of 60-90 ℃, and filtering to obtain secondary filtrate; mixing and concentrating the two filtrates until the solid content is 10-20%, and performing spray drying to obtain licorice extract powder for later use;
4) pulverizing flos Sophorae Immaturus into powder with a pulverizer, and sieving with a 20-mesh sieve to obtain raw material powder; then adding the raw material powder into deionized water with the weight 5-8 times of that of the raw material powder, stirring and extracting for 4-6 hours at the temperature of 60-90 ℃, and filtering to obtain primary filtrate; adding deionized water with the weight being 3-6 times that of the primary extraction slag, stirring and extracting for 2-4 hours at the temperature of 60-90 ℃, and filtering to obtain secondary filtrate; and combining and concentrating the two filtrates until the solid content is 10-20%, and performing spray drying to obtain sophora flower bud extract powder for later use.
CN202010235022.1A 2020-03-26 2020-03-26 Plant essence for preventing, treating and repairing scar hyperplasia and preparation method thereof Active CN111388522B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010235022.1A CN111388522B (en) 2020-03-26 2020-03-26 Plant essence for preventing, treating and repairing scar hyperplasia and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010235022.1A CN111388522B (en) 2020-03-26 2020-03-26 Plant essence for preventing, treating and repairing scar hyperplasia and preparation method thereof

Publications (2)

Publication Number Publication Date
CN111388522A true CN111388522A (en) 2020-07-10
CN111388522B CN111388522B (en) 2021-12-28

Family

ID=71411311

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010235022.1A Active CN111388522B (en) 2020-03-26 2020-03-26 Plant essence for preventing, treating and repairing scar hyperplasia and preparation method thereof

Country Status (1)

Country Link
CN (1) CN111388522B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113208107A (en) * 2021-04-01 2021-08-06 王允太 Health-care pomelo oil and preparation method thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102038780A (en) * 2009-10-23 2011-05-04 孙治永 External medicine for treating burns and preparation method thereof
CN102274298A (en) * 2011-08-26 2011-12-14 天津嘉氏堂科技有限公司 Scar rehabilitating solution and preparation method thereof
CN104666161A (en) * 2013-12-03 2015-06-03 天津尖峰弗兰德医药科技发展有限公司 Traditional Chinese medicine skin whitening and freckle-removing cream
CN108837119A (en) * 2018-07-19 2018-11-20 北京雪胆生物科技有限公司 A kind of reparation Essence and preparation method thereof for preventing and treating the scar surface of a wound

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102038780A (en) * 2009-10-23 2011-05-04 孙治永 External medicine for treating burns and preparation method thereof
CN102274298A (en) * 2011-08-26 2011-12-14 天津嘉氏堂科技有限公司 Scar rehabilitating solution and preparation method thereof
CN104666161A (en) * 2013-12-03 2015-06-03 天津尖峰弗兰德医药科技发展有限公司 Traditional Chinese medicine skin whitening and freckle-removing cream
CN108837119A (en) * 2018-07-19 2018-11-20 北京雪胆生物科技有限公司 A kind of reparation Essence and preparation method thereof for preventing and treating the scar surface of a wound

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
刘加宁: "《美容整形外科学》", 31 July 2001, 中国劳动社会保障出版社 *
刘珀: "《中医养生精华十讲》", 31 December 2016, 中医古籍出版社 *
史丽萍等: "《实用中医药膳学》", 31 January 2019, 中国医药科技出版社 *
孟胜男: "《药剂学》", 31 January 2012, 上海科学技术出版社 *
曾强等: "《小方法大健康》", 30 June 2008, 北京出版社 *
朱婷等: "三七皂苷R1不同给药方式对皮肤创伤愈合作用的影响", 《中国药理学通报》 *
王象腾等: "三七治疗疤痕疙瘩", 《中医杂志》 *
苏珊•柯蒂斯等: "《自然美妆宝典》", 30 November 2018, 中国轻工业出版社 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113208107A (en) * 2021-04-01 2021-08-06 王允太 Health-care pomelo oil and preparation method thereof

Also Published As

Publication number Publication date
CN111388522B (en) 2021-12-28

Similar Documents

Publication Publication Date Title
Razia et al. Synergistic effect of Aloe vera flower and Aloe gel on cutaneous wound healing targeting MFAP4 and its associated signaling pathway: In-vitro study
Yassine et al. A topical ointment formulation containing leaves’ powder of Lawsonia inermis accelerate excision wound healing in Wistar rats
CN111388522B (en) Plant essence for preventing, treating and repairing scar hyperplasia and preparation method thereof
CN104127685A (en) Application of external-use plaster composition in preparation of drug used for treating skin injury
CN102266373A (en) Skin externally-used matrix for treating scar and preparation method thereof
JP4498145B2 (en) Therapeutic compositions containing organic extracts of radish and use of organic extracts of radish
Gupta et al. Evaluation of Prosopis cineraria (Linn.) Druce leaves for wound healing activity in rats
Rajan et al. Wound healing activity of an herbal ointment containing the leaf extract of Ziziphus mauritiana Lam
CN113712999B (en) Application of Zhuang medicine xue Dang dry paste powder in preparation of anti-inflammatory analgesic medicine
CN105168941A (en) Traditional Chinese medicine preparation for promoting cesarean wound healing and preparation method therefor
Periyanayagam et al. Wound healing activity of the leaves of Artocarpus heterophyllus Lam.(Moraceae) on ex-vivo porcine skin wound healing model
CN108096318A (en) Treat pharmaceutical composition of cardiovascular and cerebrovascular disease and its preparation method and application
Abdulrasool et al. A Relative Assess on Wound Healing and Anti-Scar Activity of Crude Echinops heterophyllus Extract and Some of its Bioactive Fractions
CN106620402A (en) Traditional Chinese medicine composition taken after operation of liver cancer and preparation method thereof
Suharto et al. The effect of the mahkota dewa (Phaleria macrocarpa) on the density of collagen incision wounds
CN109700850B (en) Traditional Chinese medicine ointment for promoting wound healing and preparation method thereof
CN107126555A (en) A kind of pigskin collagen small peptide active component composition of wound healing
Satish et al. Evaluation of Wound Healing Activity of Catharanthus Roseus Aqueous Extract in Adult Albino Rats.(2021)
CN104547758A (en) Medicine for treating qi-deficiency and blood-stasis type keloid and preparation method thereof
CN106266109A (en) A kind of Chinese medicine composition treating urinary system calculus and preparation method thereof
CN106880654B (en) Application of panax japonicus extract in preparing medicine for treating rhinitis and composition
CN105640797B (en) Dihydromyricetin and application of the bletilla polysaccharide composition in beautifying whitening
CN104623304A (en) Lotion for treating chronic skin ulcer caused by damp-heat and toxicity accumulation and preparation method of lotion
Alwan et al. Immunohistochemical evaluation of epidermal growth factor expression in skin wound treated by capparis spinosa flavonoid extract in alloxan induced diabetes rats
Permata et al. Beyond Traditional Boundaries: A Review on Calotropis gigantea’s Efficacy in Wound Healing

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CP02 Change in the address of a patent holder

Address after: 100176 floor 2, building 1, No. 18, Longqing street, Beijing Economic and Technological Development Zone

Patentee after: CHENFENG natural herbal (Beijing) Technology Co.,Ltd.

Address before: 100005 1921b, floor 17, No. 5, Jianguomen North Street, Dongcheng District, Beijing

Patentee before: CHENFENG natural herbal (Beijing) Technology Co.,Ltd.

CP02 Change in the address of a patent holder
DD01 Delivery of document by public notice

Addressee: Patent of CHENFENG natural herbal (Beijing) Technology Co.,Ltd. The person in charge

Document name: Notification of procedure qualification

DD01 Delivery of document by public notice